CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mallinckrodt ARD LLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mallinckrodt ARD LLC
1425 U.S. Route 206
Phone: (714) 786-4200p:714 786-4200 Bedminster, NJ  07921  United States Fax: (714) 789-4229f:714 789-4229
This company was Merged or Acquired on 8/14/2014.
This company ceased filing statements with the SEC on 8/25/2014.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Mallinckrodt ARD LLC, also known as Questcor Pharmaceuticals, Inc. (Questcor), is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications. Its research and development program is focused on: the evaluation of the use of Acthar for certain on-label indications; the investigation of other potential uses of Acthar for indications not FDA approved; and the expansion of its understanding of how Acthar works in the human body (pharmacology), and ultimately, its mechanisms of action in the disease states for which it is used, or may be used in the future. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201412/31/2013YesYesYes-Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Virgil D.Thompson 74 1/1/2009 1/1/1996
President, Chief Executive Officer, Director Don M.Bailey 68 11/29/2007 5/1/2006
Chief Financial Officer, Senior Vice President RajeshAsarpota 47 2/17/2014 2/17/2014
9 additional Officers and Directors records available in full report.

Business Names
Business Name
QCOR
Questcor International Limited
Questcor Operations Limited
4 additional Business Names available in full report.

General Information
Outstanding Shares: 61,448,937 (As of 6/30/2014)
Shareholders: 496
Stock Exchange: NASD
Federal Tax Id: 330476164
Fax Number: (714) 789-4229
Email Address: ir@questcor.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023